Our data show that among all breast cancer subtypes, TNBC exhibits the highest levels of AXL expression and a strong association between AXL overexpression and the mesenchymal subtype of TNBC, which is known for its increased metastatic potential and resistance to chemotherapy [17,18,19]. Here, AXL is linked to breast carcinoma.